Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M
Theranostics. 2023 Jan 1;13(1):355-373. doi: 10.7150/thno.77560
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.
Aiuti A
J Clin Invest. 117(8):2233-40.
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.
Cassani B
Blood. 2008 Jan 24;111(8):4209-19. doi: 10.1182/blood-2007-05-092429
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
Guerrini MM
Am J Hum Genet. 83(1):64-76. doi: 10.1016/j.ajhg.2008.06.015
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Aiuti A
N Engl J Med. 360(5):447-58. doi: 10.1056/NEJMoa0805817
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.
Cassani B
Blood. 2009 Aug 3;114(17):3546-56. doi: 10.1182/blood-2009-02-202085
Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome.
Cassani B
J Exp Med. 2010 Jun 14;207(7):1525-40. doi: 10.1084/jem.20091928
Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases.
Villablanca EJ
Gastroenterology. 140(6):1776-84. doi: 10.1053/j.gastro.2011.02.015
Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice.
Cassani B
Gastroenterology. 2011 Sep 16;141(6):2109-18. doi: 10.1053/j.gastro.2011.09.015
Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.
Pala F
J Clin Invest. 2015 Sep 14;125(10):3941-51. doi: 10.1172/JCI82249